ClinicalTrials.gov
public full text
Public Domain
A Dose-Ranging Study of JNJ-40411813 in Healthy Male Volunteers
The purpose of this study is to characterize the 5-HT2A binding over the maximum feasible dose range of JNJ-40411813, to estimate the plasma concentration associated with 50% 5-HT2A binding, and to investigate the safety and tolerability of JNJ-40411813 in healthy male volunteers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male Participants#980946
- A Study of JNJ-64251330 in Healthy Participants#1211071
- A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors#872254
- A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult Participants#879295
- A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants#1364157
Record · ID 1454727
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive